Articles Tagged With:
-
Menopausal Hormone Replacement
For women who use or have used hormone replacement for menopausal symptoms, new data should be reassuring that their symptom relief does not come at a cost of increased total or cancer-related mortality.
-
Is It Safe to Use PPIs Long Term?
Proton pump inhibitors (PPIs) are among the most widely used medications in the United States, thanks to a generally favorable combination of efficacy, tolerability, and safety. Because such a large portion of the adult population uses PPIs, even if a small fraction experiences an adverse effect, it becomes a potentially important issue.
-
The Long-term Picture After Bariatric Surgery
While often viewed as a last-resort treatment of obesity, bariatric surgery actually is the only intervention demonstrated to improve obesity-related mortality. Strict criteria for payment by insurers and costs that are inaccessible to most of the uninsured have restricted the population who could benefit from bariatric surgery.
-
Opioid-induced Nausea and Vomiting
Opioids are highly effective when administered for appropriate indications. Unfortunately, opioid-induced nausea and/or vomiting (OINV) can limit opioid effectiveness. In the immediate postoperative period, OINV can stress wound integrity and prolong hospital stay. In the outpatient setting, some patients are faced with the dilemma of accepting lesser levels of pain control in exchange for less OINV as they consider whether they should decrease their opioid dosing schedule.
-
FDA Actions
In this section: The FDA unveils new adverse events dashboard tool, announces intent to hasten generic drug approvals, greenlights a generic drug to treat multiple sclerosis, greenlights biosimilar to treat multiple types of cancers, gives go ahead to leukemia treatment, and approves updated herpes zoster vaccine.
-
Possible Adverse Cardiovascular Events Slow Osteoporosis Drug Approval Process
Romosozumab appears to outperform alendronate for fracture prevention in women with osteoporosis, but an increase in cardiovascular adverse events has derailed FDA approval.
-
Comparing Two Important Hormone Therapy Treatments
New data from the Women’s Health Initiative may be reassuring for women on postmenopausal hormone therapy. The data show no higher mortality rate with hormone use after long-term follow-up.
-
What Is the Appropriate Length of Opioid Prescriptions After Routine Surgeries?
Postsurgical opioid prescriptions often lead to extra pills stored in unsecured locations in homes. This represents a potential source for non-medical opioid use and associated morbidity and mortality for patients and their families.
-
Making the Most of a High-deductible Plan Environment
It was just in one summer month, but Bluffton Okatie Surgery Center in Bluffton, SC, logged a cash collection rate of 100.2%.
-
For Your Consideration: A Few Interesting FAQs and Answers
Stephen Earnhart answers reader questions on communication, investing, and electronic medical records.